The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
818350811 8183508 11 F 201107 20160701 20111017 20160705 EXP BR-ROCHE-1001873 ROCHE 59.65 YR F Y 50.00000 KG 20160705 OT BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
818350811 8183508 1 PS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 INFUSION
818350811 8183508 2 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 INFUSION
818350811 8183508 3 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 103705 INFUSION
818350811 8183508 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) MOST RECENT DOSE 22/OCT/014, 400 MG/20ML; LAST DOSE: 19/JAN/2016 125276 INFUSION /month
818350811 8183508 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 INFUSION
818350811 8183508 6 C MELOXICAM. MELOXICAM 1 0
818350811 8183508 7 C CYCLOBENZAPRINE CYCLOBENZAPRINE 1 0
818350811 8183508 8 C MAGNOPYROL 2 0
818350811 8183508 9 C METHOTREXATE. METHOTREXATE 1 Oral 0 2.5 MG TABLET BIW
818350811 8183508 10 C MAGNOPYROL 2 Intravenous drip 50 DROPS IN THE MORNING, FOR PAIN, SINCE 30 YEARS, (IF PERSISTENT, PATIENT TAKES IT DAILY) 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
818350811 8183508 1 Rheumatoid arthritis
818350811 8183508 4 Rheumatoid arthritis
818350811 8183508 9 Rheumatoid arthritis
818350811 8183508 10 Pain

Outcome of event

Event ID CASEID OUTC COD
818350811 8183508 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
818350811 8183508 Abasia
818350811 8183508 Abdominal pain upper
818350811 8183508 Arthralgia
818350811 8183508 Disease progression
818350811 8183508 Drug ineffective
818350811 8183508 Fall
818350811 8183508 Fatigue
818350811 8183508 Hepatic enzyme increased
818350811 8183508 Hypertension
818350811 8183508 Mobility decreased
818350811 8183508 Rash
818350811 8183508 Rheumatoid arthritis
818350811 8183508 Spinal osteoarthritis
818350811 8183508 Therapeutic response decreased
818350811 8183508 Tooth disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
818350811 8183508 1 20100501 0
818350811 8183508 2 20101201 0
818350811 8183508 3 20111011 20111025 0
818350811 8183508 4 20140722 0
818350811 8183508 5 20140624 0
818350811 8183508 9 20150204 0
818350811 8183508 10 1985 0